National Vision (EYE)
(Delayed Data from NSDQ)
$17.73 USD
-1.11 (-5.89%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $17.71 -0.02 (-0.11%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Average Brokerage Rating
Current ABR | 2.44 |
ABR (Last week) | 2.44 |
# of Recs in ABR | 9 |
Average Target Price | $22.75 |
LT Growth Rate | 14.50% |
Industry | Medical - Products |
Industry Rank by ABR | 152 of 252 |
Current Quarter EPS Est: | 0.28 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.44 | 2.44 | 2.44 | 2.44 | 2.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/28/2024 | Loop Capital Markets | Anthony C Chukumba | Strong Buy | Strong Buy |
11/9/2023 | William Blair | Dylan Carden | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.